Innovation
Innovation
Improving Health for All
We develop new ways to promote faster development of valuable treatments and ensure diverse patient groups can access them.
Featured White Paper
The Elasticity of Pharmaceutical Innovation: How Much Does Revenue Drive New Drug Development?
For every 10% reduction in expected revenues, we can expect 2.5% to 15% less pharmaceutical innovation. Policymakers should take care to balance reductions in health outcomes long-term with short-term access improvements.
Experts: Karen Van Nuys, Darius Lakdawalla, Dana Goldman
Top Innovation Stories View All
Perspective
Benchmarking Drug Prices To Inflation Overlooks What Truly Matters: Value
Featured Experts: William Padula
In The News View All
MedPage Today
Kanter discusses changes in staffing and decision-making at the FDA
Featured Experts: Genevieve P. Kanter
Associated Press
Padula comments on the difficulty of assessing the potential effects of the White House’s drug pricing deals
Featured Experts: William Padula
Axios
Schiller discusses opportunities to strengthen U.S. competitiveness in early-phase clinical research
Featured Experts: Lowell Schiller
KFF Health News
FDA’s shift away from independent drug reviews could shield the agency from scrutiny, Kanter says
Featured Experts: Genevieve P. Kanter
STAT
FDA staff cuts may undermine agency promises on “radical transparency” and fewer conflicts of interest, Kanter explains
Featured Experts: Genevieve P. Kanter
Related Subtopics
High drug prices may garner headlines, but innovation must be appropriately incentivized to help solve healthcare’s intractable challenges. We connect industry, academia and government to support the scientific and technological creativity that saves and improves lives — and spurs economic growth.
Team View All Innovation Experts
